Cohort IMEA 070 -Lenacapavir Compassional
Immunovirological follow-up and safety of HIV-infected patients receiving lenacapavir under compassionate access in France between 01/01/2021 and 12/31/2023
- EligibilityCriteria: Inclusion Criteria:  Patients who received compassionate access to LEN between 01/01/2021 and 20/12/202  Exclusion Criteria:  Absence of visits with virological assessment subsequent to inclusion visit Participant opposition to use of follow-up data - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult - StudyPopulation: Patients already followed and identified in the centers and having received lenacapavir in compassionate access between January 01st, 2021 and December 20th, 2022 - SamplingMethod: Non-Probability Sample